THCB, short for tetrahydrocannabutol, is a rare phytocannabinoid that occurs naturally in the cannabis plant in very small quantities. It is also written as Δ9-THCB, delta-9-THCB, or THC-C4. Scientific research has identified it as a butyl homologue of delta-9-tetrahydrocannabinol (Δ9-THC), meaning the two compounds have closely related structures but differ in the length of their alkyl side chain.
Unlike the much more abundant cannabinoids such as Δ9-THC and CBD, THCB is present only at trace levels in cannabis. Its scarcity has made it a subject of scientific interest as researchers investigate the chemical diversity of cannabis and the biological activity of lesser-known cannabinoids.
What Does THCB Stand For?
THCB stands for tetrahydrocannabutol.
The name reflects its relationship with tetrahydrocannabinol compounds and its butyl side chain. It is sometimes referred to as THC-C4, with “C4” indicating the four-carbon alkyl side chain that distinguishes it structurally from the five-carbon side chain of Δ9-THC.
Common names and abbreviations include:
- THCB
- THC-B
- Δ9-THCB
- Δ9-tetrahydrocannabutol
- Delta-9-tetrahydrocannabutol
- THC-C4
- Butyl-THC
THCB as a Phytocannabinoid
A phytocannabinoid is a cannabinoid produced naturally by a plant. Cannabis produces a large variety of phytocannabinoids, many of which occur only in very small amounts.
THCB belongs to this group of naturally occurring cannabis compounds. Researchers identified and characterized Δ9-THCB in cannabis using analytical techniques including high-resolution mass spectrometry and nuclear magnetic resonance spectroscopy.
Because it occurs naturally in the plant, THCB is different from cannabinoids that are created entirely through synthetic chemistry. However, commercially available cannabinoid products may contain cannabinoids produced or concentrated through processing, so the presence of THCB in a product does not necessarily mean that the compound was obtained directly from cannabis in its naturally occurring concentration.
How Is THCB Different From THC?
The most important structural difference between THCB and Δ9-THC is their alkyl side chain.
Δ9-THC has a five-carbon pentyl side chain, whereas THCB has a four-carbon butyl side chain. This seemingly small structural difference can influence how a cannabinoid interacts with cannabinoid receptors and how it behaves biologically.
Both compounds belong to the same broader family of THC-related cannabinoids, but they should not automatically be assumed to have identical effects.
THCB and the Endocannabinoid System
Cannabinoids can interact with the body’s endocannabinoid system, which includes cannabinoid receptors such as CB1 and CB2.
Laboratory research has found that THCB can bind to both CB1 and CB2 receptors. One study reported a CB1 binding affinity of approximately 15 nM and a CB2 binding affinity of approximately 51 nM.
These findings demonstrate that THCB interacts with the cannabinoid receptor system, but receptor-binding results alone do not establish how the compound affects people in real-world use.
Is THCB Psychoactive?
THCB is considered an intoxicating cannabinoid by Health Canada because available evidence indicates that it can bind to and activate the CB1 receptor. However, the agency emphasizes that information about the effects of cannabinoids other than Δ9-THC remains limited.
Therefore, THCB should not be assumed to produce exactly the same subjective effects or intensity as conventional Δ9-THC.
The actual effects may depend on factors including the dose, formulation, route of administration, individual physiology, and whether other cannabinoids are present.
What Does Research Say About THCB?
Research into THCB is still relatively limited.
Laboratory studies have examined its interaction with cannabinoid receptors and its effects in animal models. Research has reported cannabinoid-like activity and effects in experimental models, including findings from formalin and tetrad tests in mice.
These findings are useful for understanding the pharmacology of the compound, but animal and laboratory studies cannot establish that the same effects or benefits occur in humans.
THCB and Potential Therapeutic Effects
THCB has attracted scientific interest because of its activity at cannabinoid receptors and results observed in experimental models.
Some early studies have investigated possible analgesic and other cannabinoid-related effects. However, these findings are preliminary and do not establish THCB as a proven medical treatment.
There is currently insufficient clinical evidence to determine whether THCB is safe or effective for treating a particular medical condition in humans.
Claims that THCB can treat pain, anxiety, inflammation, or other conditions should therefore be distinguished from findings obtained in laboratory or animal research.
Why Is THCB Considered Rare?
One of the defining characteristics of THCB is its low natural abundance.
Researchers studying rare cannabinoids have noted that many minor cannabis compounds occur at concentrations far below those of the plant’s major cannabinoids. This makes extracting and studying them directly from plant material considerably more difficult.
The limited natural availability of THCB has also contributed to interest in analytical methods and alternative production approaches for studying rare cannabinoids.
THCB in Commercial Cannabis Products
Although THCB occurs naturally in cannabis at very low levels, products containing concentrated THCB have appeared in some commercial markets.
This is important because a naturally occurring trace cannabinoid and a concentrated cannabinoid product are not equivalent exposures.
Health Canada specifically identifies THCB among cannabinoids for which evidence of CB1 activation exists and notes that the effects of these cannabinoids relative to Δ9-THC are not yet fully understood.
Consumers should therefore be cautious about assuming that products marketed as “THCB” have the same safety profile as naturally occurring cannabis.
THCB Safety and Side Effects
The safety profile of THCB in humans has not been adequately established.
An EU early-warning-system notification notes that information on the pharmacology and toxicology of THCB is limited.
Because of this limited evidence, it is not possible to provide a well-established list of human side effects or a clinically validated safe dose.
Products containing intoxicating cannabinoids can also present risks related to impairment and unpredictable potency, particularly when they are manufactured outside tightly controlled pharmaceutical settings.
THCB vs. THCP
THCB and THCP are two relatively uncommon THC-related cannabinoids that have attracted scientific and commercial attention.
Their names reflect differences in their side chains:
| Cannabinoid | Side chain |
|---|---|
| THCV | Propyl, C3 |
| THCB | Butyl, C4 |
| Δ9-THC | Pentyl, C5 |
| THCH | Hexyl, C6 |
| THCP | Heptyl, C7 |
The length and structure of the side chain can influence cannabinoid-receptor interactions.
However, these structural differences do not by themselves provide a reliable way to predict how each cannabinoid will affect a person.
Is THCB the Same as Delta-9-THC?
No. THCB and Δ9-THC are different chemical compounds.
They are closely related and share a similar molecular framework, but THCB has a four-carbon butyl side chain while Δ9-THC has a five-carbon pentyl side chain.
Because of this structural difference, their pharmacological properties can differ even though both interact with the cannabinoid receptor system.
Current State of THCB Research
THCB remains an emerging and comparatively understudied cannabinoid.
Research has established its presence in cannabis and provided information about its chemical structure and receptor activity. More recent research has also examined the metabolism of Δ9-THCB and other THC homologues using human liver microsomes.
However, much more research is needed to understand its pharmacokinetics, metabolism, long-term safety, effects in humans, and potential therapeutic applications.
Frequently Asked Questions About THCB
What is THCB?
THCB, or tetrahydrocannabutol, is a rare phytocannabinoid naturally produced by cannabis plants in trace amounts.
Is THCB a natural cannabinoid?
Yes. Δ9-THCB has been identified as a naturally occurring cannabinoid in cannabis, although it occurs at very low concentrations.
Is THCB related to THC?
Yes. THCB is a structural homologue of Δ9-THC. Its main structural difference is a four-carbon butyl side chain instead of THC’s five-carbon pentyl side chain.
Can THCB cause intoxication?
THCB is classified by Health Canada among cannabinoids with evidence of CB1 receptor activation, but the available evidence is insufficient to precisely characterize its intoxicating effects in humans.
Is THCB medically proven?
No. There is currently not enough clinical evidence to establish THCB as a safe and effective treatment for a specific medical condition.
Is THCB safe?
Its human safety profile is not well established. Available scientific and regulatory sources emphasize that information about its pharmacology and toxicology remains limited.
Conclusion
THCB (tetrahydrocannabutol) is a rare, naturally occurring phytocannabinoid found in trace amounts in cannabis. It is closely related to Δ9-THC but has a four-carbon butyl side chain rather than THC’s five-carbon pentyl side chain.
Laboratory research indicates that THCB interacts with the CB1 and CB2 cannabinoid receptors, and experimental studies have investigated its cannabinoid-like and analgesic activity. However, research in humans remains limited, and its safety, effects, and potential medical applications are not yet well established.
As research into minor cannabinoids continues, THCB remains an important example of the considerable chemical diversity found within the cannabis plant.